Proefschrift

Pouchol, C., Clairambault, J., Lorz, A., and Tr´elat, E. (2018). Asymptotic analysis and optimal control of an integro-differential system modelling healthy and cancer cells exposed to chemotherapy. Journal de Math´ematiques Pures et Appliqu´ees , 116:268–308. 81 Prates, C., Sousa, S., Oliveira, C., and Ikram, S. (2011). Prostate metastatic bone cancer in an Egyptian Ptolemaic mummy, a proposed radiological diagnosis. International Journal of Paleopathology , 1(2):98–103. 4 Prostate Cancer Trialists’ Collaborative Group (1995). Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials. Lancet , 346:265–269. 5 Reid, A., Attard, G., Danila, D., Oommen, N., Olmos, D., Fong, P., Molife, R., Hunt, J., Messiou, C., Parker, C., et al. (2010). Significant and sustained antitumor activity in post-docetaxel, castration-resistant prostate cancer with the CYP17 inhibitor abiraterone acetate. Journal of Clinical Oncology , 28(9):1489–1495. 49 Resnick, M. and Penson, D. (2012). Quality of life with advanced metastatic prostate cancer. Urologic Clinics of North America , 39(4):505–515. 75 Rex Consortium et al. (2013). Heterogeneity of selection and the evolution of resistance. Trends in Ecology & Evolution , 28(2):110–118. 19 Rini, B., Melichar, B., Ueda, T., Gru¨nwald, V., Fishman, M., Arranz, J., Bair, A., Pithavala, Y., Andrews, G., Pavlov, D., et al. (2013). Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial. The Lancet Oncology , 14(12):1233–1242. 97 Roberts, A., Davids, M., Pagel, J., Kahl, B., Puvvada, S., Gerecitano, J., Kipps, T., Anderson, M., Brown, J., Gressick, L., et al. (2016). Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia. New England Journal of Medicine , 374(4):311– 322. 97 Robey, I., Baggett, B., Kirkpatrick, N., et al. (2009). Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Research , 69(6):2260–2268. 21 Rockne, R., Hawkins-Daarud, A., Swanson, K., et al. (2019). The 2019 mathematical oncology roadmap. Physical Biology , 16(4):041005. 3, 11 Rockne, R., Rockhill, J., Mrugala, M., Spence, A., Kalet, I., Hendrickson, K., Lai, A., Cloughesy, T., Alvord Jr, E., and Swanson, K. (2010). Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: a mathematical modeling approach. Physics in Medicine & Biology , 55(12):3271–3286. 53 Roviello, G., Bachelot, T., Hudis, C., Curigliano, G., Reynolds, A., Petrioli, R., and Generali, D. (2017). The role of bevacizumab in solid tumours: A literature based meta-analysis of randomised trials. European Journal of Cancer , 75:245–258. 21 183